Company intelligence / Profile preview

Mevo

São Paulo, São Paulo, Brazilmevo.com ↗

Ownership: Private
Development stage: Commercial

Overview

Mevo is a leading Brazilian healthcare technology company providing an end-to-end digital prescription platform. It enables healthcare professionals to prescribe medications, request exams, and provide referrals digitally. Prescriptions are sent directly to patients' devices. The company also offers an online pharmacy service for purchasing medications and wellness products with home delivery. As of its latest funding round in late 2024, the company has raised over $35 million to scale operations across Brazil.

Modalities: Non-pharmacological therapy
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

None disclosed

Beyond the preview

Go deeper on Mevo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mevo.

Explore the full profile